메뉴 건너뛰기




Volumn 17, Issue 4, 2008, Pages 178-180

A viewpoint on statin effects - Benefits and problems

Author keywords

[No Author keywords available]

Indexed keywords


EID: 79957484111     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278305     Document Type: Note
Times cited : (3)

References (27)
  • 1
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 2
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (LIPID) Study Group
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-57.
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 5
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of scotland coronary prevention study group
    • Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3
  • 6
    • 0025353476 scopus 로고
    • Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham heart study
    • Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990;322:1635-41. (Pubitemid 20171587)
    • (1990) New England Journal of Medicine , vol.322 , Issue.23 , pp. 1635-1641
    • Sytkowski, P.A.1    Kannel, W.B.2    D'Agostino, R.B.3
  • 7
    • 0035897696 scopus 로고    scopus 로고
    • Expert panel on detection evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 8
    • 38049034068 scopus 로고    scopus 로고
    • Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results
    • Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results. Trends Mol Med 2008;14:37-44.
    • (2008) Trends Mol Med , vol.14 , pp. 37-44
    • Wang, C.Y.1    Liu, P.Y.2    Liao, J.K.3
  • 9
    • 16544374872 scopus 로고    scopus 로고
    • Inflammation in atherothrombosis: How to use highsensitivity C-reactive protein (hsCRP) in clinical practice
    • Ridker PM. Inflammation in atherothrombosis: How to use highsensitivity C-reactive protein (hsCRP) in clinical practice. Am Heart Hosp J 2004;2:4-9.
    • (2004) Am Heart Hosp J , vol.2 , pp. 4-9
    • Ridker, P.M.1
  • 10
    • 20444402764 scopus 로고    scopus 로고
    • CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report from the clinical practice discussion group
    • Smith SC Jr, Anderson JL, Cannon RO III, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report from the clinical practice discussion group. Circulation 2004;110:e550-3.
    • (2004) Circulation , vol.110
    • Smith Jr., S.C.1    Anderson, J.L.2    Cannon III, R.O.3
  • 11
    • 4944261232 scopus 로고    scopus 로고
    • 2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from Southern Germany
    • DOI 10.1161/01.CIR.0000143377.53389.C8
    • Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from southern Germany. Circulation 2004;110:1903-8. (Pubitemid 39331899)
    • (2004) Circulation , vol.110 , Issue.14 , pp. 1903-1908
    • Koenig, W.1    Khuseyinova, N.2    Lowel, H.3    Trischler, G.4    Meisinger, C.5
  • 12
    • 39149142513 scopus 로고    scopus 로고
    • Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation. A Meta-Analysis of Randomized Controlled Trials
    • DOI 10.1016/j.jacc.2007.09.063, PII S0735109707037795
    • Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008;51:828-35. (Pubitemid 351255618)
    • (2008) Journal of the American College of Cardiology , vol.51 , Issue.8 , pp. 828-835
    • Fauchier, L.1    Pierre, B.2    De Labriolle, A.3    Grimard, C.4    Zannad, N.5    Babuty, D.6
  • 13
    • 38349150595 scopus 로고    scopus 로고
    • Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy
    • Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51:415-26.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 415-426
    • Ramasubbu, K.1    Estep, J.2    White, D.L.3    Deswal, A.4    Mann, D.L.5
  • 16
    • 0029054734 scopus 로고
    • Molecular bases of the acute coronary syndromes
    • Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
    • (1995) Circulation , vol.91 , pp. 2844-2850
    • Libby, P.1
  • 17
    • 34247262523 scopus 로고    scopus 로고
    • Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting
    • Hyre A, Krousel-Wood MA, Muntner P, Kawasake L, DeSalvo KB. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens 2007;9:179-86.
    • (2007) J Clin Hypertens , vol.9 , pp. 179-186
    • Hyre, A.1    Krousel-Wood, M.A.2    Muntner, P.3    Kawasake, L.4    Desalvo, K.B.5
  • 19
    • 0037075262 scopus 로고    scopus 로고
    • Cerivastatin and reports of fatal rhabdomyolysis
    • Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 2002;346:539-40.
    • (2002) N Engl J Med , vol.346 , pp. 539-540
    • Staffa, J.A.1    Chang, J.2    Green, L.3
  • 24
    • 34547954921 scopus 로고    scopus 로고
    • A new perspective on nonprescription statins: An opportunity for patient education and involvement
    • DOI 10.1016/j.amjcard.2007.06.009, PII S0002914907012349
    • Fuster V. A new perspective on nonprescription statins: An opportunity for patient education and involvement. Am J Cardiol 2007;100:907-10. (Pubitemid 47268288)
    • (2007) American Journal of Cardiology , vol.100 , Issue.5 , pp. 907-910
    • Fuster, V.1
  • 25
    • 41949093962 scopus 로고    scopus 로고
    • Nonprescription statins: Not ready for prime time
    • DOI 10.1016/j.amjcard.2007.09.112, PII S0002914907020966
    • Whayne TF Jr. Nonprescription statins: Not ready for prime time. Am J Cardiol 2008;101:745-746; author reply 746. (Pubitemid 351625075)
    • (2008) American Journal of Cardiology , vol.101 , Issue.5 , pp. 745-746
    • Whayne Jr., T.F.1
  • 26
    • 34247639532 scopus 로고    scopus 로고
    • Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins
    • DOI 10.1016/j.amjcard.2006.12.063, PII S000291490700255X
    • Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007;99:1409-12. (Pubitemid 46686635)
    • (2007) American Journal of Cardiology , vol.99 , Issue.10 , pp. 1409-1412
    • Caso, G.1    Kelly, P.2    McNurlan, M.A.3    Lawson, W.E.4
  • 27
    • 34249826635 scopus 로고    scopus 로고
    • The role of coenzyme Q10 in statin-associated myopathy. A systematic review
    • DOI 10.1016/j.jacc.2007.02.049, PII S0735109707010546
    • Marcoff L, Thompson PD. The role of coenzyme Q10 in statinassociated myopathy: a systematic review. J Am Coll Cardiol 2007;49:2231-7. (Pubitemid 46856819)
    • (2007) Journal of the American College of Cardiology , vol.49 , Issue.23 , pp. 2231-2237
    • Marcoff, L.1    Thompson, P.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.